July 2019 FDA Recall Drug by Amneal Pharmaceuticals, Inc.
D-1516-2019 - Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets

This Class III drug recall was voluntarily initiated by Amneal Pharmaceuticals, Inc. on July 18, 2019 for the product Drug. The FDA reported the reason for recall as presence of foreign tablet/capsule; one promethazine tablet was found in a bottle of methylergonovine maleate tablets. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1516-2019

Reason for Recall
Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets
Initiated
07-18-2019
Reported
07-31-2019
Quantity
a) 2,256 bottles; b) 240 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Amneal Pharmaceuticals, Inc.
Product was distributed to three major distributors who may have further distributed the product nationwide.
Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count (NDC 69238-1605-02) and b) 28 count bottles (NDC 69238-1605-08)

Batch or Lot Expiration Information

Lot# a)
Lot# BA10619A, b)
Lot# BA10619B, exp. date 07/2020